» Articles » PMID: 29040982

Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury

Overview
Journal Dig Dis
Specialty Gastroenterology
Date 2017 Oct 18
PMID 29040982
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Acute-onset autoimmune hepatitis (AIH) histopathologically presents with features of acute hepatitis and lacks a specific diagnostic method. Also, AIH is often difficult to differentiate from drug-induced liver injury (DILI). We aimed to investigate the final clinical diagnosis of these cases, and compare the clinical, biochemical, and histological characteristics of AIH vs. DILI.

Methods: We examined the Digestive Disease Week Japan 2004 (DDW-J) scale scores, AIH scores, clinical data, and pathological findings in 20 patients in whom it was difficult to differentiate autoimmune liver disease from DILI.

Results: In cases with a DDW-J scale score of ≥5, there was a good correlation between the final diagnosis and DDW-J scale assessments, but in cases with a DDW-J scale score of ≦4 they did not correlate well. The scores for pathological findings, such as cobblestone hepatocellular change (p = 0.015), interface hepatitis (p = 0.012), and prominent plasma cells in portal areas (p = 0.011), were higher in the AIH group than in the DILI group.

Conclusion: This study showed that DDW-J scale was useful for differentiating AIH from DILI in cases with a DDW-J scale score of ≧5. The histologic features of AIH were characterized by cobblestone hepatocellular change, interface hepatitis, and plasma cell infiltration of the portal region.

Citing Articles

Acute presentation of autoimmune hepatitis -from acute hepatitis to ALF and ACLF.

Tanaka A, Harada K Hepatol Int. 2024; 18(5):1385-1395.

PMID: 39127981 DOI: 10.1007/s12072-024-10714-1.


A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center.

Franceschini T, Vasuri F, Muratori P, Muratori L, Guido M, Lenzi M Virchows Arch. 2021; 479(5):937-945.

PMID: 34189631 PMC: 8241564. DOI: 10.1007/s00428-021-03122-5.


Differential characteristics in drug-induced autoimmune hepatitis.

Martinez-Casas O, Diaz-Ramirez G, Marin-Zuluaga J, Munoz-Maya O, Santos O, Donado-Gomez J JGH Open. 2018; 2(3):97-104.

PMID: 30483571 PMC: 6207017. DOI: 10.1002/jgh3.12054.


Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection.

Matsumoto K, Kikuchi K, Kajiyama Y, Takano Y, Mabuchi M, Doi S Intern Med. 2018; 57(18):2669-2673.

PMID: 29709942 PMC: 6191578. DOI: 10.2169/internalmedicine.0613-17.